$5.16
At close: Nov 7, 4:28 PM EDT
$5.26
0.11.94%
Pre-Market: Nov 7, 4:28 PM EDT
Comments
Loading...
Karyopharm Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:KPTI | Benzinga
Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 3
EPS
$-3.820
Quarterly Revenue
$44.00M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$142.53M
Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
KPTI | Karyopharm Therapeutics | -$3.90 | -$3.27 | -$3.82 | -16.82% | $38.78M | $42.37M | $44.00M | 3.86% | 11/03/2025 | |
KPTI | Karyopharm Therapeutics | -$2.97 | -$3.86 | -$4.32 | -11.92% | $42.79M | $38.79M | $37.93M | -2.21% | 08/11/2025 | |
KPTI | Karyopharm Therapeutics | -$4.85 | -$3.09 | -$2.77 | 10.36% | $33.13M | $35.12M | $30.02M | -14.54% | 05/12/2025 | |
KPTI | Karyopharm Therapeutics | -$5.40 | -$4.05 | -$3.60 | 11.11% | $33.75M | $35.67M | $30.54M | -14.38% | 02/19/2025 | |
KPTI | Karyopharm Therapeutics | -$4.50 | -$3.90 | -$3.90 | 0.00% | $36.01M | $37.79M | $38.78M | 2.63% | 11/05/2024 | |
KPTI | Karyopharm Therapeutics | -$4.35 | -$4.50 | -$3.00 | 33.33% | $37.58M | $36.18M | $42.79M | 18.26% | 08/06/2024 | |
KPTI | Karyopharm Therapeutics | -$4.50 | -$4.95 | -$4.80 | 3.03% | $38.70M | $34.47M | $33.13M | -3.90% | 05/08/2024 | |
KPTI | Karyopharm Therapeutics | -$6.45 | -$4.65 | -$5.40 | -16.13% | $33.58M | $35.40M | $33.75M | -4.67% | 02/29/2024 | |
KPTI | Karyopharm Therapeutics | -$6.75 | -$4.20 | -$4.50 | -7.14% | $36.15M | $37.28M | $36.01M | -3.41% | 11/02/2023 | |
KPTI | Karyopharm Therapeutics | -$9.30 | -$5.10 | -$4.35 | 14.71% | $39.68M | $36.23M | $37.58M | 3.72% | 08/02/2023 | |
KPTI | Karyopharm Therapeutics | -$7.95 | -$5.55 | -$4.50 | 18.92% | $47.67M | $36.60M | $38.70M | 5.73% | 05/04/2023 | |
KPTI | Karyopharm Therapeutics | $6.90 | -$5.25 | -$6.45 | -22.86% | $126.27M | $35.12M | $33.58M | -4.38% | 02/15/2023 | |
KPTI | Karyopharm Therapeutics | -$10.35 | -$8.55 | -$6.75 | 21.05% | $37.69M | $34.56M | $36.15M | 4.59% | 11/03/2022 | |
KPTI | Karyopharm Therapeutics | -$10.65 | -$9.45 | -$9.30 | 1.59% | $22.60M | $35.59M | $39.68M | 11.49% | 08/04/2022 | |
KPTI | Karyopharm Therapeutics | -$11.55 | -$9.45 | -$7.95 | 15.87% | $23.26M | $34.17M | $47.67M | 39.51% | 05/05/2022 | |
KPTI | Karyopharm Therapeutics | -$8.85 | -$7.35 | $6.90 | 193.88% | $35.10M | $50.49M | $126.27M | 150.09% | 02/08/2022 | |
KPTI | Karyopharm Therapeutics | -$10.95 | -$10.05 | -$10.35 | -2.99% | $21.33M | $25.80M | $37.69M | 46.08% | 11/03/2021 | |
KPTI | Karyopharm Therapeutics | -$9.45 | -$11.10 | -$10.65 | 4.05% | $33.51M | $25.64M | $22.60M | -11.85% | 08/05/2021 | |
KPTI | Karyopharm Therapeutics | -$11.70 | -$10.65 | -$11.55 | -8.45% | $18.14M | $25.17M | $23.26M | -7.59% | 05/03/2021 | |
KPTI | Karyopharm Therapeutics | -$11.40 | -$0.59 | -$8.85 | -1400.00% | $18.10M | $29.37M | $35.10M | 19.51% | 02/11/2021 |
Karyopharm Therapeutics (KPTI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $-3.82 | $-3.27 | -16.8 % |
| Q2 | 2025-08-11 | $-4.32 | $-3.86 | -11.9 % |
| Q1 | 2025-05-12 | $-2.77 | $-3.09 | 10.4 % |
| Q4 | 2025-02-19 | $-3.60 | $-4.05 | 11.1 % |
Karyopharm Therapeutics (KPTI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $44.00M | $42.37M | 3.86 % |
| Q2 | 2025-08-11 | $37.93M | $38.79M | -2.21 % |
| Q1 | 2025-05-12 | $30.02M | $35.12M | -14.5 % |
| Q4 | 2025-02-19 | $30.54M | $35.67M | -14.4 % |
FAQ
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics (KPTI) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 3, 2025 for Q3.
What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?
Karyopharm Therapeutics (KPTI) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 3, 2025 for Q3 and the Actual EPS was $-3.82, which missed the estimate of $-3.27.
What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?
Karyopharm Therapeutics (KPTI) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 3, 2025 for Q3 and the Actual Revenue was $44M, which beat the estimate of $42.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
